BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 24513602)

  • 1. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A; Giuliani C
    Minerva Endocrinol; 2014 Mar; 39(1):33-41. PubMed ID: 24513602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatremia in cancer patients.
    Platania M; Verzoni E; Vitali M
    Tumori; 2015; 101(2):246-8. PubMed ID: 25908038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hyponatremia: role of vaptans].
    Hensen J
    Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review: the use of vaptans in clinical endocrinology.
    Peri A
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
    Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasopressin receptor antagonists: the vaptans].
    Villabona C
    Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L; Schmidt PH; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
    Velasco Cano MV; Runkle de la Vega I
    Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion.
    Verbalis JG
    Endocrinol Nutr; 2010 May; 57 Suppl 2():30-40. PubMed ID: 21130960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyponatremia: new developments and controversies].
    Hensen J
    Dtsch Med Wochenschr; 2011 Apr; 136(17):904-9. PubMed ID: 21523644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C; Balbiano R; Caramello P; Roccatello D
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyponatremia and syndrome of inappropriate ADH secretion (SIADH)].
    Peri A; Parenti G; Giuliani A; Scrivano J; Pettorini L; Festuccia F; Pirozzi N; Mene' P
    G Ital Nefrol; 2012; 29(6):661-73. PubMed ID: 23229664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
    Gross PA; Wagner A; Decaux G
    Kidney Int; 2011 Sep; 80(6):594-600. PubMed ID: 21451459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasopressin antagonists in treatment of hyponatremia].
    Olszewski W; Głuszek J
    Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].
    Foppiani L; Raggi F; Tagliabue M; Benso A; Brandolin I; Lo Pinto G
    Recenti Prog Med; 2013 Mar; 104(3):112-5. PubMed ID: 23548955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Wada K; Matsukawa U; Fujimori A; Arai Y; Sudoh K; Sasamata M; Miyata K
    Biol Pharm Bull; 2007 Jan; 30(1):91-5. PubMed ID: 17202666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal dysnatremia].
    Karaca P; Desailloud R
    Ann Endocrinol (Paris); 2013 Oct; 74 Suppl 1():S42-51. PubMed ID: 24356291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Peri A; Pirozzi N; Parenti G; Festuccia F; Menè P
    J Endocrinol Invest; 2010 Oct; 33(9):671-82. PubMed ID: 20935451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.